Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Exosomes Research Market Share Estimated to Surpass USD 1,896 Million By 2030, at 31.5% CAGR Growth: Polaris Market Research

Polaris_Market_Research_Logo

News provided by

Polaris Market Research

Nov 14, 2022, 07:41 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Polaris Market Research recently published [115+ Pages] research report on "Exosome Research Market Share, Size, Trends, Industry Analysis Report, By Product (Kits and Reagents, Instruments, Other Products); By Indication; By Application; By Region; Segment Forecast, 2022 - 2030" in its research database.

According to the research report, the global exosome research market size & share demand was valued at USD 163.5 million in 2021 and is estimated to surpass USD 1,896 Million By 2030, growing at a CAGR of 31.5% during the forecast period.

What are Exosomes Research? What is Expected Size & Share of Exosomes Research Market?

  • Overview

Exosomes are membrane-bound extracellular vesicles that are generated by eukaryotic cells and they contain various proteins, RNAs, DNAs, bioactive lipids, and metabolites. Applications of exosomes are associated with immune responses, pregnancy, cardiovascular diseases, cancer progression, and viral pathogenicity. In recent years, interest in exosome research has increased due to their pleiotropic physiological and pathological functions.

They also have abilities to alter recipient cell bioactivities and potential in disease diagnostics and drug delivery. There are more than 4,400 articles published about exosomes, of which approximately 25% were released in 2016 alone. Some of the prominent factors driving the exosome research market demand includes increasing cases of cancer, significant scientific developments in exosome technology and research.

Request Sample Copy of "Exosomes Research Market" Research Report @ https://www.polarismarketresearch.com/industry-analysis/exosome-research-market/request-for-sample

Our Free Sample Report Includes

  • Report introduction, overview, and in-depth industry analysis
  • Breakdown data by regions, type, players, and applications
  • Competitive landscape and leading competitor market shares
  • 110+ pages research report
  • Offers chapter-wise instruction on request
  • Includes market presence across different geographies with share, size, and trends
  • Updated list of tables and figures
  • The report covers leading players with their business strategies
  • Factors and fact research methodology

Some of the Top Market Players Are:

  • Thermo Fisher Scientific
  • System Biosciences
  • Bio-Techne
  • Lonza
  • QIAGEN
  • ExoDx
  • Hitachi Chemical
  • Aethlon Medical
  • NanoSomiX
  • Malvern Panalytical
  • Sistemic Scotland Limited
  • NX PharmaGen
  • Miltenyi Biotec
  • AMS Biotechnology
  • Norgen Biotek
  • Novus Biologicals
  • BioVision
  • Pall Corporation
  • Exopharm
  • EverZom

For Additional List of Players and Detail Information, Download a Report PDF Brochure

Growth Driving Factors

  • Rising investments by pharma companies in R&D to flourish the market growth

Exosomes carries functional substances such as circulating nucleic acids, lipids, and proteins which fuels the exosome research market size. Exosomes has a key role in immunosurveillance and tumor pathogenesis which encourages research programs emphasizing on explaining the functions of exosomes in hepatocellular carcinoma (HCC). This is one of the major factors boosting the industry expansion. Also, rising technological developments for the separation, representation, and recognition of exosomes, as well as a growing clinical studies and research exosome research.

Moreover, the application of these vesicles in research activities associated to therapeutics and diagnostics is expected to propel the exosome research market sales over the forecast period. Rising investments by governments to modernize health care infrastructure in developing countries is anticipated to raise access to health care, thus bolstering the demand for exosome research products. In addition, a surge in investment by pharmaceutical companies in R&D to produce efficient and advanced products is boosting the industry growth.

Directly Purchase a copy of report with TOC @ https://www.polarismarketresearch.com/checkouts/17411

Recent Developments

In February 2022, Bio-Techne Corporation announced an agreement with Thermo Fisher Scientific to exclusively complete development of and commercialize the ExoTRU kidney transplant rejection test developed by Exosome Diagnostics, a Bio-Techne brand.

Segmental Analysis

  • Kits & reagents segment is expected to account largest share over the forecast period

Based on product exosome research market segmentations, the kits and reagents category held the highest revenue share in 2021. easy-to-use kits and reagents are used to precisely characterized exosomes. Also, the important processes of isolation and purification are needed for exosome research approaches that accelerates their general commercialization. For instance, standardized exosome separation kits can address exosome and EV heterogeneity. With these kits, exosomes and EV can be extracted from different biological fluids, including serum, plasma, and blood.

  • Neurodegenerative disease segment is anticipated to lead the market

Based on indication, the neuro-degenerative diseases segment witnessed the largest exosome research market share in 2021. This is because neurodegenerative diseases are the growing cause of disability and mortality. Also, substantial financial burden on healthcare systems is contributing to the segment growth. As per a United Nations report, the number of dementia cases in developed nations is anticipated to increase from 13.5 million in 2000 to 21.2 million in 2025 to 36.7 million in 2050.

Request for Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/exosome-research-market/request-for-discount-pricing

Exosome Research Market: Report Scope

Report Attribute

Details

Revenue forecast in 2030

USD 1,896 Million

Market size value in 2022

USD 212.0 Million

Expected CAGR Growth

31.5% from 2022 - 2030

Base Year

2021

Forecast Year

2022 - 2030

Top Market Players

Thermo Fisher Scientific, System Biosciences, Bio-Techne, Lonza, QIAGEN, ExoDx, Hitachi Chemical, Aethlon Medical, NanoSomiX, Malvern Panalytical, Sistemic Scotland Limited, NX PharmaGen, Miltenyi Biotec, AMS Biotechnology, Norgen Biotek, Novus Biologicals, BioVision, Pall Corporation, Exopharm, and EverZom.

Segments Covered

By Product, By Indication, By Application, By Region

Customization Options

Customized purchase options are available to meet any research needs. Explore customized purchase options

Geographic Overview

  • The North America is likely to dominate the market

By geography, North America witnesses the highest revenue share in exosome research market due to well-developed healthcare infrastructure, a sizable population of multinational enterprises, favorable public guidelines, and a growing public awareness regarding diagnostics and healthcare. Further, increasing prevalence of chronic diseases, rising product launches for exosome therapeutics, growing development of R&D activities in pharmaceutical and biopharmaceutical industry are some of the factors boosting the regional growth in exosome research industry.  For instance, in April 2021, EV Therapeutics and the University of Minnesota Medical School announced a partnership to introduce an Exosome-based therapeutic method for treating colorectal cancer.

Browse the Detail Report "Exosome Research Market Share, Size, Trends, Industry Analysis Report, By Product (Kits and Reagents, Instruments, Other Products); By Indication; By Application; By Region; Segment Forecast, 2022 - 2030" with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/exosome-research-market 

For Additional Information OR Media Enquiry, Please Mail At: [email protected]

Polaris Market Research has segmented the exosome research market report based on product, indication, application, and region:

By Product Outlook

  • Kits and Reagents
  • Instruments
  • Other Products
  • By Indication
  • Cancer
  • Neurodegenerative diseases
  • Cardiovascular diseases
  • Infectious diseases
  • Others

By Application Outlook

  • Biomarkers
  • Vaccine Development
  • Tissue Regeneration
  • Other Applications

By Region Outlook

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Healthcare Research Reports:

  • Medical Terminology Software Market: https://www.polarismarketresearch.com/industry-analysis/medical-terminology-software-market
  • Digital Pharmacy Market: https://www.polarismarketresearch.com/industry-analysis/digital-pharmacy-market
  • AI-based Clinical Trial Solutions For Patient Matching Market: https://www.polarismarketresearch.com/industry-analysis/ai-based-clinical-trial-solutions-for-patient-matching-market
  • Stem Cell Market: https://www.polarismarketresearch.com/industry-analysis/stem-cell-market
  • Dermatology Device Market: https://www.polarismarketresearch.com/industry-analysis/dermatology-devices-market

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

Contact:

Likhil G 
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: [email protected]  
Web: https://www.polarismarketresearch.com 
Follow US: LinkedIn | twitter

Logo: https://mma.prnewswire.com/media/1316207/Polaris_Market_Research_Logo.jpg

SOURCE Polaris Market Research

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.